HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 69, Issue 1, 2010, Pages 305-308

  Jacobi, A M ^a   Mei, H ^b   Hoyer, B F ^a   Mumtaz, I M ^a   Thiele, K ^a   Radbruch, A ^a,b   Burmester, G R ^a   Hiepe, F ^a,b   Dorner T ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD27 ANTIGEN; DIPHTHERIA TETANUS TOXOID; DOUBLE STRANDED DNA ANTIBODY; HLA DR ANTIGEN; IMMUNOGLOBULIN; ANTINUCLEAR ANTIBODY; BIOLOGICAL MARKER; IMMUNOGLOBULIN G;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BONE MARROW; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; PLASMABLAST; PRIORITY JOURNAL; SECRETORY CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; BONE MARROW CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD27; B-LYMPHOCYTE SUBSETS; BIOLOGICAL MARKERS; BONE MARROW CELLS; COHORT STUDIES; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; PLASMA CELLS;

EID: 73449114618     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.096495     Document Type: Article

References (15)

1. Bijl M, Horst G, Limburg PC, et al. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis 2001;60:523-6.
2. Grammer AC, Lipsky PE. B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther 2003;5(Suppl 4):S22-7.
3. Hutloff A, Buchner K, Reiter K, et al. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum 2004;50:3211-20.
4. Jacobi AM, Odendahl M, Reiter K, et al. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2003;48:1332-42.
5. Odendahl M, Jacobi A, Hansen A, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000;165:5970-9.
6. Odendahl M, Mei H, Hoyer BF, et al. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 2005;105:1614-21.
7. Piskurich JF, Lin KI, Lin Y, et al. BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat Immunol 2000;1:526-32.
8. Cassese G, Lindenau S, de Boer B, et al. Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur J Immunol 2001;31:2726-32.
9. Hoyer BF, Moser K, Hauser AE, et al. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med 2004;199:1577-84.
10. Capolunghi F, Cascioli S, Giorda E, et al. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol 2008;180:800-8.
11. Jacobi AM, Reiter K, Mackay M, et al. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum 2008;58:1762-73.
12. Rahman ZS, Manser T. Failed up-regulation of the inhibitory IgG Fc receptor Fc gamma RIIB on germinal center B cells in autoimmune-prone mice is not associated with deletion polymorphisms in the promoter region of the Fc gamma RIIB gene. J Immunol 2005;175:1440-9.
13. Mackay M, Stanevsky A, Wang T, et al. Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med 2006;203:2157-64.
14. Fukuyama H, Nimmerjahn F, Ravetch JV. The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat Immunol 2005;6:99-106.
15. Rahman ZS, Alabyev B, Manser T. FcgammaRIIB regulates autoreactive primary antibody-forming cell, but not germinal center B cell, activity. J Immunol 2007;178:897-907.